Search Results - "Prebay, D"

Retrospective analysis of bevacizumab use in combination with irinotecan for recurrent glioblastoma: a single-institution experience by Besson, C, Waissi, W, Velten, M, Nguyen Them, L, Schott, R, Prebay, D, Etienne-Selloum, N

Get full text

Recurrent or metastatic head and neck squamous cell carcinoma (RM HNSCC): What about second-line chemotherapy combining cetuximab and platinum-doublet after EXTREME protocol? by Regnier-Gavier, O, Coliat, P, Carinato, H, Burgy, M, Exinger, D, Fischbach, C, Kalish-Weindling, M, Ferry, R, Flesch, H, Bronner, G, Hemar, P, Schultz, P, Prebay, D, Borel, C

Get full text

Complementary and alternative medicines taken by cancer patients by Simon, L, Prebay, D, Beretz, A, Bagot, J-L, Lobstein, A, Rubinstein, I, Schraub, S

“…244 cancer patients from 2 public hospitals (one adult, one pediatric) and one private clinic receiving chemotherapy were asked about complementary and…”
Get more information

Médecines complémentaires et alternatives suivies par les patients cancéreux en France by SIMON, L, PREBAY, D, BERETZ, A, BAGOT, J.-L, LOBSTEIN, A, RUBINSTEIN, I, SCHRAUB, S

Get full text

328 - Retrospective analysis of bevacizumab use in combination with irinotecan for recurrent glioblastoma: a single-institution experience by Besson, C., Waissi, W., Velten, M., Nguyen Them, L., Schott, R., Prebay, D., Etienne-Selloum, N.

Get full text

RETROSPECTIVE ANALYSIS OF LONG-TERM RESPONSE TO BEVACIZUMAB IN COMBINATION WITH IRINOTECAN FOR RECURRENT GLIOBLASTOMA: IDENTIFICATION OF PROGNOSTIC FACTORS by Besson, C., Morisse, M., Brut, H., Waissi, W., Noel, G., Chauffert, Bruno, Prebay, D., Schott, R., Etienne-Selloum, N.

Get full text

914 - Recurrent or metastatic head and neck squamous cell carcinoma (RM HNSCC): What about second-line chemotherapy combining cetuximab and platinum-doublet after EXTREME protocol? by Regnier-Gavier, O., Coliat, P., Carinato, H., Burgy, M., Exinger, D., Fischbach, C., Kalish-Weindling, M., Ferry, R., Flesch, H., Bronner, G., Hemar, P., Schultz, P., Prebay, D., Borel, C.

Get full text

Place des consultations radiopharmaceutiques dans la prise en charge de l’hyperthyroïdie en médecine nucléaire by Hammer, C., Keita Camara, F., Porot, C., Schneegans, O., Bourahla, K., Coliat, P., Prebay, D.

“…La pharmacie Clinique faisant partie intégrante des missions de la Pharmacie à Usage Intérieur, des consultations radiopharmaceutiques (CR) ont été instaurées…”
Get full text

Évaluation de la satisfaction des patients traités par irathérapie en médecine nucléaire selon deux circuits : en ambulatoire ou en hôpital de jour by Porot, C., Hammer, C., Keita Camara, F., Bourahla, K., Schneegans, O., Coliat, P., Prebay, D.

“…Les recommandations de radioprotection et leur respect étant primordiaux, une prise en charge (PEC) en hospitalisation de jour (HDJ) a été instaurée pour des…”
Get full text

P14.125 Retrospective analysis of long-term response to bevacizumab in combination with irinotecan for recurrent glioblastoma: identification of prognostic factors by Besson, C, Morisse, M, Brut, H, Waissi, W, Noel, G, Chauffert, B, Prébay, D, Schott, R, Etienne-Selloum, N

“…Abstract BACKGROUND In absence of standard treatment for recurrent glioblastoma (rGBM), numerous prospective and retrospective studies have evaluated the…”
Get full text

Complementary and alternative medicines taken by cancer patients,Médecines complémentaires et alternatives suivies par les patients cancéreux en France by Simon, L, Prebay, D., Beretz, Alain, Bagot, J.-L., Lobstein, Annelise, Rubinstein, I, Schraub, S

Get full text

Medecines complémentaires et alternatives suivies par les patients cancéreux en France by Simon, L., Prebay, D., Beretz, A., J.L., Bagot, Lobstein, A., Rubionstein, I., Schraub, S.

Get full text

Analysis of hematopoietic growth factor prescriptions in 19 french cancer centers by Gautié, L, Canal, P, Menguy, A, Latour, J F, Bénard, I, Courbard, M, Brunelle, P, Carpentier, Y, Pinguet, F, Chevrier, R, Doly, M, Watelet, M, Brière, M, Viau, P, Duban, M, German, O, Gosselin, P, de La Jarriage, P L, Bertrand, C, Pommier, M, Prebay, D

“…Medical prescription of hematopoietic growth factors (HGF) was analysed in 19 anticancer french centers during 2 months. About 4% of anticancer…”
Get full text

1515 or 1995? The applicable regulations for a pharmacist at the Hospital of Strasbourg by Prebay, D, Lagrange, M, Bachoffner, P, Koffel, J C

Get more information

Analyse de la prescription de facteurs de croissance hématopoïétique dans 19 centres anticancéreux français by GAUTIE, L, CANAL, P, DOLY, M, WATELET, M, BRIERE, M, VIAU, P, DUBAN, M, GERMAN, O, GOSSELIN, P, DE LA JARRIGE, P. L, BERTRAND, C, POMMIER, M, MENGUY, A, PREBAY, D, LATOUR, J.-F, BENARD, I, COURBARD, M, BRUNELLE, P, CARPENTIER, Y, PINGUET, F, CHEVRIER, R

Get full text